The University of California San Diego launched the Center for Innovative Phage Applications and Therapeutics (IPATH) to develop bacteriophages to fight multidrug-resistant bacteria. The initial focus will be on treating chronic infections associated with cystic fibrosis, organ transplantation and implantable hardware. The center hopes to start clinical trials by year end.
{iframe}https://www.biocentury.com/bc-extra/company-news/2018-06-21/ucsd-launches-bacteriophage-treatment-center{/iframe}